Number of the records: 1
inhibítory SGLT2
SYS d000077203 LBL 00000cz--a2200181n--4500 005 20250606222638.8 008 190101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 $d BA006 065 $a D27.505.519.936 065 $a D27.505.696.422.750 066 $a 01 $c 03 150 $a inhibítory SGLT2 $x AD $x AE $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Gliflozin $2 eng 450 $w v $a SGLT-2 Inhibitor $2 eng 450 $w v $a SGLT2 Inhibitor $2 eng 450 $w v $a Sodium-Glucose Transporter 2 Inhibitor $2 eng 450 $w v $a inhibítory sodíkovo-glukózového transportéra 2 $2 slo 450 $w v $a inhibítor sodíkovo-glukózového transportéra 2 $2 slo 450 $w v $a inhibítory transportéra sodíka a glukózy 2 $2 slo 450 $w v $a gliflozín $2 slo 450 $w v $a gliflozíny $2 slo 665 $a 2019 $2 eng 680 9-
$i Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS. $2 eng 750 -2
$a Sodium-Glucose Transporter 2 Inhibitors $2 eng 980 $x M
Number of the records: 1